Facilities and resources

Laboratory resources and equipment plan

Grant proposals have to show where the work will be done and with what. This page lists the capabilities our projects need, grouped by priority, so that partner institutions and core facilities can see where their resources fit.

How to read this plan

Not everything here needs to be bought. Many items exist in university core facilities and partner laboratories, and using them is often better science and a better use of grant funds. For each capability, a proposal will state whether it is provided by OncoFirm, by a named partner or requested in the budget.

Capabilities by area

Immunoassay and lateral flow development

Reagent dispensing, strip lamination and cutting, conjugation, drying and controlled-humidity storage.

Antibody, protein and biomarker work

Protein quantification, plate-based immunoassays for reference comparison, and purification and labeling tools.

Fluorescence and optical development

Fluorescence readers and imaging, a spectrometer, optical bench components and reference standards.

Analytical validation and quality control

Calibrated pipettes and balances, environmental and stability chambers, and traceable measurement standards.

Clinical specimen handling

A Class II biological safety cabinet, centrifuges, and monitored cold storage at 2–8°C, −20°C and −80°C.

Prototype manufacturing

3D printing and cassette assembly tools, automated dispensing and inspection as work scales.

Data and computing

Secure storage, analysis workstations and version-controlled software development.

General laboratory infrastructure

Benches, safety equipment, purified water and waste handling.

Priority tiers

TierPurposeExamplesLikely source
I. EssentialFeasibility and prototype workPipettes, balances, centrifuges, cold storage, fluorescence reader, microplate reader, strip dispenser and cutter, biosafety cabinetPartner laboratory or first-stage grant budget
II. Advanced developmentOptimization and analytical validationFluorescence imaging, spectrometer, environmental chambers, 3D prototyping, automated dispensingCore facilities, second-stage grant budget
III. Scale-up and clinicalValidation lots and clinical studiesAutomated assembly, vision inspection, reader calibration stations, expanded specimen storage and computingManufacturing partner, later-stage funding

Human-specimen work is conducted only under applicable biosafety, IRB, institutional, contractual and regulatory requirements.

If your facility can help

Core facilities, incubators and partner laboratories can be written into a proposal as a resource, with user fees or a subaward budgeted for. Tell us what you have through a collaboration inquiry. Partner roles and agreements explains how facility access is documented, and the grant programs page lists the program types in scope.

Frequently asked questions

Not necessarily. Access to specific capabilities, such as a biosafety cabinet and cold storage for specimen work, can be enough for a defined task.

Often yes, within each program’s limits and with justification. Reviewers generally prefer use of existing facilities where they are available.

No. It is a statement of capabilities the research requires, shared so partners can see where they could contribute.

Research and regulatory status

OncoFirm™ technologies described on this site are in research and development. Their performance characteristics have not been established, and no OncoFirm product has been cleared, approved or authorized by the U.S. Food and Drug Administration. Nothing here is medical advice. Reference to a federal agency or funding program does not imply endorsement, funding, sponsorship or affiliation.